Predictive value of integrative epigenetic profiling in metastatic melanoma (MM) patients (p) treated with BRAF/MEK inhibitors (BMI) and chemotherapy (CT).

被引：0

作者：

Luis Manzano, Jose

Martinez Cardus, Anna

Teresa Fernandez-Figueras, Maria

Boada, Aram

Luis Cuadra-Urteaga, Jose

Morain, Sebastian

Buges, Cristina

de los Llanos Gil, Maria

Layos, Laura

Indacochea, Alberto

Vila Martinez, Laia

Hardy, Max

Teruel, Iris

Martinez-Balibrea, Eva

Esteller, Manel

机构：

[1] Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol, Badalona, Spain

[2] Fdn Res Inst Hlth Sci Germans Trias & Pujol, Badalona, Spain

[3] Hosp Badalona Germans Trias & Pujol, Pathol Serv, Barcelona, Spain

[4] Hosp Badalona Germans Trias & Pujol, Dermatol Serv, Barcelona, Spain

[5] Univ Autonoma Barcelona, Inst Catala Oncol Badalona, HU Germans Trias & Pujol, Badalona, Spain

[6] Idibell, Barcelona, Spain

[7] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Dept Med Oncol, Barcelona, Spain

[8] Hosp Univ Germays Trias & Pujol, Barcelona, Spain

[9] Hosp Badalona Germans Trias & Pujol, Instut Catala Oncol, Med Oncol, Barcelona, Spain

[10] Inst Invest Germans Trias & Pujol, Inst Catala Oncol, Badalona, Spain

[11] Inst Invest Biomed Bellvitge, Barcelona, Spain

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e20059

引用

页数：1